If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> RHEUMATOLOGY<br /> ISSAID supplement • emjreviews.com<br /> INSIDE<br /> From Bench to Bedside:<br /> Targeting the IL-1β Pathway in<br /> Autoinflammatory Diseases<br /> FROM BENCH TO BEDSIDE: TARGETING THE IL-1β<br /> PATHWAY IN AUTOINFLAMMATORY DISEASES<br /> This symposium took place on 1st October 2015 as part<br /> of ISSAID 2015: the International Society of Systemic<br /> Auto-inflammatory Diseases’ 8th International Congress<br /> of Familial Mediterranean Fever and Systemic<br /> Auto-inflammatory Diseases in Dresden, Germany<br /> Chairperson<br /> Gerd Horneff1<br /> Speakers<br /> Angelo Ravelli,2 Jasmin B Kümmerle-Deschner,3 Fabrizio De Benedetti4<br /> 1. Asklepios Clinic, Sankt Augustin, Germany<br /> 2. University of Genoa, Istituto Giannina Gaslini, Genoa, Italy<br /> 3. Division of Paediatric Rheumatology,<b<a title="EMJ Rheumatol. 2016 Suppl 4 page 1" href="http://viewer.zmags.com/publication/36a4d069?page=1"> RHEUMATOLOGY ISSAID supplement • emjreviews.com </a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 2" href="http://viewer.zmags.com/publication/36a4d069?page=2"> FROM BENCH TO BEDSIDE: TARGETING THE IL-1β PAT</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 3" href="http://viewer.zmags.com/publication/36a4d069?page=3"> Recent Advances in Understanding the Role of IL-</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 4" href="http://viewer.zmags.com/publication/36a4d069?page=4"> with onset in infancy [SAVI]), those caused by in</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 5" href="http://viewer.zmags.com/publication/36a4d069?page=5"> He had recurrent fever episodes beginni</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 6" href="http://viewer.zmags.com/publication/36a4d069?page=6"> JADAS27-CRP score over time, particularly in the </a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 7" href="http://viewer.zmags.com/publication/36a4d069?page=7"> were included, of which 109 were children; follow</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 8" href="http://viewer.zmags.com/publication/36a4d069?page=8"> A Canakinumab administration Screening (1 month)</a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 9" href="http://viewer.zmags.com/publication/36a4d069?page=9"> REFERENCES 1. Drenth JP, van der Meer </a> <a title="EMJ Rheumatol. 2016 Suppl 4 page 10" href="http://viewer.zmags.com/publication/36a4d069?page=10"> 39. Kümmerle-Deschner J et al. SAT0524 Evaluation</a>